Physician profile
Joel Woods
NPI 1194215582
$5,054.43
in general payments reported to CMS, 2019-2025
18 companies · $922 in 2025
The $922 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $281 · 2021: $796 · 2022: $1,368 · 2023: $802 · 2024: $742 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,446 · Entertainment: $19.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,446.32 |
| Entertainment | $19.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $964.60 | 2019-2025 | Dailies Total1, Precision7, Rocklatan |
| Bausch & Lomb Americas INC. | $773.20 | 2022-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $649.69 | 2020-2021 | |
| Coopervision INC. | $548.23 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Oyster Point Pharma, INC. | $466.70 | 2022-2025 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $331.19 | 2020-2025 | Acuvue |
| Abbvie INC. | $231.06 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Tarsus Pharmaceuticals, INC. | $173.57 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $153.56 | 2022 | |
| Glaukos Corporation | $139.86 | 2022 | |
| Kala Pharmaceuticals, INC. | $112.22 | 2021 | |
| Allergan, INC. | $110.73 | 2021-2022 | |
| Dompe US, INC. | $84.34 | 2024-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $71.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $71.20 | 2022-2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $69.98 | 2022-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $67.60 | 2022-2024 | |
| New World Medical,INC. | $35.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.